Mission Viejo, CA, United States of America

Feras Hantash

This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Nucleic Acid Detection. Top assignees: Quest Diagnostics Investments, Inc., Research Development Foundation. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Feras Hantash. Retrieved from https://idiyas.com/inventor/feras-hantash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 7)

% Patents Active = 91.7

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

Dana Point, CA (US) (2006 - 2018)
San Juan Capistrano, CA (2021)
Mission Viejo, CA (US) (2009 - 2022)
San Juan Capistrano, CA (US) (2018 - 2024)

Company Filing History:

23 out of 499

Quest Diagnostics Investments, Inc.

patents

1 out of 299

Research Development Foundation

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Thyroid Cancer

MLH1 Methylation

Nucleic Acid

Sanger Sequencing

Cystic Fibrosis

Mutation Detection

Amplification Techniques

Genetic Screening

TPMT Mutations

Gene Mutations

Universal Sequencing

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516372 - COMPOSITIONS AND METHODS FOR SCREENING MUTATIONS IN THYROID CANCER (2026-01-06),

2. 12460252 - MLH1 methylation assay (2025-11-04),

3. 12264357 - Universal Sanger sequencing from next-gen sequencing amplicons (2025-04-01),

4. 11993820 - Methods of detecting MLH1 methylation (2024-05-28),

5. 11840726 - MLH1 methylation assay (2023-12-12),

6. 11466325 - Method to detect repeat sequence motifs in nucleic acid (2022-10-11),

7. 11085079 - Universal Sanger sequencing from next-gen sequencing amplicons (2021-08-10),

8. 11053542 - Compositions and methods for screening mutations in thyroid cancer (2021-07-06),

9. 10982288 - Methods of detecting MLH1 methylation (2021-04-20),

10. 10883138 - MLH1 methylation assay (2021-01-05),

11. 10655179 - Cystic fibrosis transmembrane conductance regulator gene mutations (2020-05-19),

12. 10233497 - Method to detect repeat sequence motifs in nucleic acid (2019-03-19),

13. 10155982 - Method for detecting cystic fibrosis (2018-12-18),

14. 10138519 - Universal sanger sequencing from next-gen sequencing amplicons (2018-11-27),

15. 9863000 - Cystic fibrosis transmembrane conductance regulator gene mutations (2018-01-09),

Title: The Innovative Journey of Feras Hantash

Introduction: Feras Hantash, a talented inventor based in Mission Viejo, CA, has made significant contributions to the field of technology with his creative solutions and groundbreaking inventions.

Latest Patents: Feras Hantash holds several patents in various technological domains, showcasing his versatility and ingenuity in creating novel solutions to complex problems.

Career Highlights: Throughout his career, Feras Hantash has demonstrated a keen ability to identify gaps in the market and develop innovative products that meet the needs of consumers. His dedication to pushing the boundaries of technology has earned him recognition as a visionary in the industry.

Collaborations: Feras Hantash has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Feras Hantash's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His continued dedication to creating cutting-edge solutions is sure to inspire future generations of inventors and entrepreneurs.

Profile summary based on public USPTO records.